Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Oct;26(1):35–41.

Double-stranded DNA-binding capacity of serum in acute and chronic liver disease.

S Jain, R Markham, H C Thomas, S Sherlock
PMCID: PMC1540802  PMID: 1087214

Abstract

Serum antibodies to double-stranded 'native' DNA have been measured in acute and chronic liver diseases using the Farr technique. Elevated levels of DNA binding were found in all groups of patients, with the highest levels in acute viral hepatitis and lowest in primary biliary cirrhosis. All patients with hepatitis B surface antigen-positive chronic active hepatitis had elevated levels, hence persistent elevation of DNA binding after acute type B hepatitis might be an unfavourable prognostic marker indicating progression to chronic active hepatitis, DNA antibody levels will not offer diagnostic help in liver diseases, or help to follow the response of patients with 'lupoid' hepatitis to corticosteroid therapy. Production of DNA antibody may be a response to release of DNA from damaged hepatocytes.

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COWLING D. C., MACKAY I. R., TAFT L. I. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. doi: 10.1016/s0140-6736(56)91483-0. [DOI] [PubMed] [Google Scholar]
  2. Carr R. I., Koffler D., Agnello V., Kunkel H. G. Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate. Clin Exp Immunol. 1969 May;4(5):527–536. [PMC free article] [PubMed] [Google Scholar]
  3. Davis G. L., Jr, Davis J. S., 4th Detection of circulating DNA by counterimmunoelectrophoresis (CIE). Arthritis Rheum. 1973 Jan-Feb;16(1):52–58. doi: 10.1002/art.1780160108. [DOI] [PubMed] [Google Scholar]
  4. Davis P., Read A. E. Antibodies to double-stranded (native) DNA in active chronic hepatitis. Gut. 1975 Jun;16(6):413–415. doi: 10.1136/gut.16.6.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  6. Dudley F. J., O'Shea M. J., Ajdukiewicz A., Sherlock S. Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease. Gut. 1973 May;14(5):360–364. doi: 10.1136/gut.14.5.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harbeck R. J., Bardana E. J., Kohler P. F., Carr R. I. DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest. 1973 Apr;52(4):789–795. doi: 10.1172/JCI107242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harbeck R. J., Hoffmann A. A., Carr R. I. Studies on the nature of circulating DNA in systemic lupus erythematosus (SLE). J Rheumatol. 1975 Jun;2(2):194–203. [PubMed] [Google Scholar]
  9. Hughes G. R., Cohen S. A., Christian C. L. Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis. 1971 May;30(3):259–264. doi: 10.1136/ard.30.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
  11. Johnson G. D., Holborow E. J., Glynn L. E. Antibody to smooth muscle in patients with liver disease. Lancet. 1965 Oct 30;2(7418):878–879. doi: 10.1016/s0140-6736(65)92505-5. [DOI] [PubMed] [Google Scholar]
  12. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klatskin G., Kantor F. S. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med. 1972 Oct;77(4):533–541. doi: 10.7326/0003-4819-77-4-533. [DOI] [PubMed] [Google Scholar]
  14. Kredich N. M., Skyler J. S., Foote L. J. Antibodies to native DNA in systemic lupus erythematosus. A technique of rapid and quantitative determination. Arch Intern Med. 1973 May;131(5):639–644. [PubMed] [Google Scholar]
  15. Lindstedt G., Lundberg P. A., Iwarsson S., Lindberg J. Circulating heat-labile DNA binder(s) in chronic active hepatitis and rheumatoid arthritis. Clin Chim Acta. 1975 Jul 9;62(1):183–185. doi: 10.1016/0009-8981(75)90301-0. [DOI] [PubMed] [Google Scholar]
  16. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  17. Popper H. The immunologic basis of liver disease. Bull N Y Acad Med. 1975 Apr;51(4):519–527. [PMC free article] [PubMed] [Google Scholar]
  18. Samaha R. J., Irvin W. S. Deoxyribonucleic acid strandedness. Partial characterization of the antigenic regions binding antibodies in lupus erythematosus serum. J Clin Invest. 1975 Aug;56(2):446–457. doi: 10.1172/JCI108111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sherlock S. Chronic hepatitis. Gut. 1974 Jul;15(7):581–597. doi: 10.1136/gut.15.7.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  21. Thomas H. C., McSween R. N., White R. G. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet. 1973 Jun 9;1(7815):1288–1291. doi: 10.1016/s0140-6736(73)91300-7. [DOI] [PubMed] [Google Scholar]
  22. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES